chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flare of transverse myelitis; flare of transverse myelitis; nauseous; sore throat; headache; A spontaneous report was received from a retired physical therapist who was also a 55 year-old female patient who was administered Moderna's COVID-19 vaccine (mRNA-1273) and developed headache, sore throat (oropharyngeal pain), nauseous (nausea), and flare of transverse myelitis (myelitis transverse and condition aggravated).  The patient's medical history included transverse myelitis. Concomitant medications included mesalazine.  On 04-MAR-2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (lot# 013A21A) intramuscularly in the left arm for the prophylaxis of COVID-19 infection.  Initially, the patient reported she was fine. Then, at night on 04-MAR-2021, the patient developed headache, sore throat, then every 6 hours, she became nauseous. Early morning on 07-MAR-2021, the patient became really nauseous and went back to sleep. She reported that she had a mild flare of transverse myelitis "which doesn't happen without big insult." The flare included spasticity, weakness, and apraxia. Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not reported.   The outcomes of events, headache, oropharyngeal pain, nausea, and transverse myelitis flare, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
(L) arm edema/induration 7 cm minimal erythema and ROM secondary pain.
severe soreness and pain at the funny bone joint at the left elbow. continuing after24 hours since vaccination..
Sever abdominal pain and swelling. Unable to eat without pain and diarrhea for the first 2 months. The diarrhea got better but the pain and bloating and continued and progressively gotten worse.
Chills, body aches, N, fever (103.8), weakness, HA, rapid heartbeat, dizziness.   By 6pm I had a low grade fever and HA.  By 730p the temp was 102.8 with chills/muscle pain/tremors/nausea.  Began the fever reducing strategy.  No response - fever continued to climb and symptoms became worse until about 11pm.  Temp was 103.8 -took additional meds, cool water soak.  Temp finally began to respond and came back down in the 102 range.  Continued fever for an additional 4-5 hours.   I took fever reducers and cool water.  I was able to keep the temperature below 104.  I did not seek medical attention.
Knees and shoulders feel like arthritis after the shots. I could not walk on 1 leg for over 2 weeks, didn't run for over a month. I had trouble sleeping, headaches, neck aches and was getting heat exhaustion easily. I had to go to the doctor for intestinal infection and anemia. I am still being treated and tested by a civilian doctor. They cannot find out why I am anemic or had the infection.
Client woke up screaming @ 2am. Patient had raise red spots over body. They called ER- Couldn't  say without seeing her. They put her in Aveno bath and gave Benadryl meltaway. Mom thought she was better. Next morning she woke up with the same symptom. Rubbed Aveno cream on her which lessens the redness. Mother brought child in to Hospital on the trunk of her body, noted " fading hives" after calling to Hospital, mother was going to take patient there to have Dr exam her.
7 cm werical by 5 cm horizontal area of swelling and tenderness under the skin. No Hives and erythema no increased warmth
3/26/08 PRESENTED TO ER 3/27/08 IN DRS OFFICE C/O CHILLS FEVER & NAUSEA. Z-PACK & PHENERGAN PRESCRIBED. NO LABS DONE
This spontaneous report as received from a nurse practitioner refers to multiple unspecified patients of unknown age. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date the patients were vaccinated with improperly stored GARDASIL 9 (lot # M020103 and expiry date 15-FEB-2016). These vaccines were exposed to 46.8 F for 78 minutes. No adverse effects were reported. This is one of the several reports received from same reporter. Additional information has been requested.
Info has been received from a 42 year old female pt with allergies to gluten and antibiotics and a history of a spinal injury who on 11/15/02 was vaccinated with a dose of Hep-B. There was no concomitant medication. On 11/17/02, the pt experienced abdominal pain and a fever. The pt's abdominal pain persisted. No medical attention was sought.
Tired and fatigued, increased thyroid meds, frequent illness sore throat, headaches etc,   Dr diagnosed Re activation of mono EBV.
BLOOD CLOTS IN LEG; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included unspecified oral contraceptives.  On an unspecified date (10 days after vaccination), the patient had blood clots in leg and was treated with unspecified blood thinners. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots in leg was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210629309.; Sender's Comments: V0:20210629530-COVID-19 VACCINE AD26.COV2.S-Blood clots in leg. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: CONMEDS-OTHER SUSPECT DRUGS
Approximately 30 minutes after receiving vaccination reports sore throat and neck painful to touch.  States lymph nodes on both sides of neck became painful to touch.  No difficulty swallowing but reported throat felt like she "had strep throat".  Approximately 45 minutes after injection was taken to ER for evaluation.  Case was given Benadryl and Tylenol.  Released to return home. 24 hours following injection continued to have sore throat however lymph nodes were no longer painful to touch.  Reports symptoms continued to improve over the next 48 hours and 96 hours after injection all symptoms had resolved.
Rash and redness around the abdomen, both armpits, both shoulders and on back; itchy like mosquito bites on abdomen, armpits, both shoulders, and back.; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RASH (Rash and redness around the abdomen, both armpits, both shoulders and on back) and PRURITUS (itchy like mosquito bites on abdomen, armpits, both shoulders, and back.) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).  On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced RASH (Rash and redness around the abdomen, both armpits, both shoulders and on back) and PRURITUS (itchy like mosquito bites on abdomen, armpits, both shoulders, and back.). At the time of the report, RASH (Rash and redness around the abdomen, both armpits, both shoulders and on back) and PRURITUS (itchy like mosquito bites on abdomen, armpits, both shoulders, and back.) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  Treatments: hydrocortisone cream and Benadryl.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Hospitalization for UTI, acute metabolic encephalopathy, COVID-19 infection, elevated troponin level, atrial fibrillation, hyperglycemia, macrocytic anemia, physical deconditioning, chronic lower extremity/toe wound on dates 10/17/2023- 10/21/2023. Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
stopped breathing; Initial information received on 27-Jan-2021 regarding an unsolicited valid serious case received from a consumer via media.  This case involves patient (unknown demographics) who experienced stopped breathing (apnoea), while he/she received vaccine INFLUENZA VACCINE.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious stopped breathing (apnoea) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was also reported that havent had one since 1978 and cant have one. Almost died stopped breathing.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.  Information on the batch number was requested.; Sender's Comments: This case involves a patient (unknown demographics) who had apnoea, after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Onset of body aches 24 hours after vaccine, 30hours after vaccine developed nausea and vomiting, then developed fever of 101.7.  Sore arm into neck rated at 8/10 scale.  Has taken tylenol.
positive COVID-19 test with no symptoms; positive COVID-19 test with no symptoms; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2nd via an unspecified route of administration on 11Feb2021 as single dose, dose 1st via an unspecified route of administration on 21Jan2021 (Lot Number: 4176) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was going to have a family gathering on Easter Sunday. Out of an abundance of caution, he had a COIVD-19 RT-PCR test and it tested positive on 31Mar2021. He wanted to know if the vaccine can cause a positive result in a COVID-19 test. He said that he shows no symptoms, he doesn't feel sick, and he feels like it is a false positive. The outcome of events was unknown.   Information on the lot/batch number has been requested
Guillain Barre 6/20/07-records received from facility for DOS 4/29-5/5/07- DC DX: Guillain-Barre Syndrome. Presented with paresthesia for 1 weeks. First noticed having a left eye twitch and numbness to left face preceded by tingling and paresthesias of fingers and toes. Treated with IVIg. Only mild residuals at discharge. PE:neuro fair strength in upper extremities and lower extremities, absent reflexes mainly in lower extremities. No sensory deficit, downgoing plantars, no muscle wasting. Gait peroneal.
Blindness in left eye, blood clot in left eye- no treatment available. Permanently blind in left eye now.
Patient presented as new pt to the practice.  He had two state immunization records - same name, DOB.  The first record had zero covid vaccines listed.  The second had two previous COVID vaccines listed.  So our office gave him what we presumed to be dose #3.  But the state database that listed 2 previous dosses was wrong and he erroneously received dose #1 as bivalent.
I have chills, serve headache, body ache, fatigue, and weakness right after the shot. These lasted for about 2 days. On Jan 5th, I was tested positive for Covid-19. I had sneezing, chill, headache, nausea, fatigue, and SOB. Some of the symptoms are still ongoing. I am having chest pain and my blood pressure is evaluated all the time now. I went to see my doctor and to find out what is going on with my heart.
eye pain some times in both eyes and sometimes only one eye; pain; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the second dose of BNT162B2 via an unspecified route of administration on the left arm on 16May2021 at 12:15 PM (Lot Number: EW0185) at the age of 54-year-old as single dose for COVID-19 immunization. Medical history was none. COVID prior vaccination was none. COVID tested post vaccination was none. Other vaccine in four weeks was none. Known allergies was none. Other medications in two weeks was none. Concomitant medication were not reported. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 25Apr2021 at 11:0 AM (Lot Number: EW0165) at the age of 54-year-old as single dose for COVID-19 immunization. On 18May2021 at 06:30 AM, the patient had pain. Reported as:  It was there for 3 days and then went away. I never had this issue before taking covid-19 vaccine, since then I have been getting eye pain some times in both eyes and sometimes only one eye. The pain stays for couple of days and goes away. No treatment was not received. The outcome of eye pain was not recovered. The outcome of pain was recovered on 21May2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (vaccination site warmth), FEELING ABNORMAL (Foggy feeling in head), ASTHENIA (energy decreased), VACCINATION SITE PAIN (vaccination site pain) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE WARMTH (vaccination site warmth) and VACCINATION SITE PAIN (vaccination site pain). On an unknown date, the patient experienced FEELING ABNORMAL (Foggy feeling in head), ASTHENIA (energy decreased) and HEADACHE (headache). At the time of the report, VACCINATION SITE WARMTH (vaccination site warmth), FEELING ABNORMAL (Foggy feeling in head), ASTHENIA (energy decreased), VACCINATION SITE PAIN (vaccination site pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not reported.
Severe thrombocytopenia; This spontaneous case was reported by a physician and describes the occurrence of THROMBOCYTOPENIA (Severe thrombocytopenia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced THROMBOCYTOPENIA (Severe thrombocytopenia) (seriousness criteria hospitalization, medically significant and life threatening). At the time of the report, THROMBOCYTOPENIA (Severe thrombocytopenia) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient experienced the event after administration of the 2nd dose.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
I gave the child Tdap, MENACTRA. He was nervous, wanted a drink. We have him a juice. I gave the BARDASIL and he fainted and had what appeared to be a brief seizure. No fall or injury. He regained consciousness immediately. Squad called. He did not go to ER.
Severe soreness in left arm and wrist. The arm soreness dissipated after approximately one week. I continue to have severe soreness in my left wrist which prevents me from fully utilizing my left hand for everyday activities. Immediately after the vaccination I also felt tingling in the wrist area.
Narrative: Pt was a 98 yo M with a PMH of CAD and HLD who passed away at a facility. No cause of death given.
Pt recvd 1st dose of Hep B vax JAN91 & in MAR91 pt recvd 2nd dose Hep B & JUN91 devel muscle twitching which was not observable but was present on an MEG: @ the time of the report pt exp persisted & pt remained under tx;
leg pain after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (leg pain after receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (leg pain after receiving the vaccine). At the time of the report, PAIN IN EXTREMITY (leg pain after receiving the vaccine) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Child received vaccines 6/27/2018, following day child reduced his PO intake, he slept longer, high pitched crying, arching of the back, none consolable, he developed temperatures of 102.5F and continued with temperatures over the weekend for 3 days. He followed up in his previous PCP office 3d after the imm with fevers, per mom she was told that it was a low grade temp, did not believe it was d/t vaccines, and that it was viral. Did not take child to ER, was monitoring at home, mom thought he would resolve.
Injection site reaction. (Redness, swelling, itchy, painful). The following day after the vaccine was administered.
Small rash on day 1&2 after shot. Day 6.5, large raised hot rash. Itchy.  Currently on Zyrtec. Will begin benedryl
Information has been received from a Registered Nurse (R.N) concerning herself with no pertinent medical history and no known drug allergies/drug reactions, who on 17-MAR-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) intradermally. There was no concomitant medication. It was reported that the patient developed a 3 inch by 1 inch lump at the site of injection. It was reported that the area was also red and sore. The patient sought unspecified medical attention. There were no laboratory diagnostic tests performed. It was reported that the patient was recovering at the time of the report. Additional information has been requested.
Flushing and tingling feeling; pt left and came back about ten minutes after she left; vitals were normal and was told to take Benadryl and monitor herself
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 25-Jun-2021. On 11-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient was treated with MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) ongoing since an unknown date at an unspecified dose and frequency. On 11-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            No concomitant medications were provided.  Treatment medication also included an over the counter allergy pill. Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable
Patient woke up on Sat with severe headache/migraine, nausea, and chills (didn't take temperature). Around 7 pm a red rash appeared at and around the injection site. She experienced extreme fatigue also. On Sunday she still had a rash that extended down to about the elbow and still had headache and fatigue. On Monday she was feeling 90% better but still had nausea, headache and pink rash.
Diarrhea leaking out of diaper waking my daughter up from her nap. Didn't realize it was a reaction at the time. Was not told this could happen. Not listed on VIS.
rash-allergy, hives, anaphylactic rxn w/in 30 mins of inj;convulsive episode-hypotonic, hyporesponsive; pt recovered; f/u on 13SEP95 found pt recovered;
Sinus infection; Runny nose; Scratchy throat; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection), RHINORRHOEA (Runny nose), THROAT IRRITATION (Scratchy throat) and PYREXIA (Fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SINUSITIS (Sinus infection), RHINORRHOEA (Runny nose), THROAT IRRITATION (Scratchy throat) and PYREXIA (Fever). The patient was treated with DOXYCYCLINE for Sinus infection, at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection), RHINORRHOEA (Runny nose), THROAT IRRITATION (Scratchy throat) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-048239 (Patient Link).